SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Paion
An SI Board Since November 2006
Posts SubjectMarks Bans Symbol
10 10 0 PA8.F
Emcee:  dr.praveen Type:  Moderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10PAION SEES CONTINUED DEVELOPMENT RATIONALE FOR DESMOTEPLASE BASED ON FINDINGS Ftnsaf-10/20/2007
9FRX Drops Desmoteplase: siliconinvestor.comDewDiligence_on_SI-8/30/2007
8ESTAT: Snake-venom drug ineffective in stroke beyond standard three-hour treatmedr.praveen-11/26/2006
7New Treatment for Ischemic Stroke on the Horizon November 14, 2006 — The launchdr.praveen-11/21/2006
6Looks like a little sell off today coz the investors knew there will be another dr.praveen-11/13/2006
5Paion R&D Day slides library.corporate-ir.net Paion is finalising the plandr.praveen-11/12/2006
4Doctors launch new effort to treat stroke more effectively Just a small fractiodr.praveen-11/11/2006
3Thanks Harry...My head is a little muddled now and excuse me for any mistakes. dr.praveen-11/1/2006
2Praveen: Good luck with the new thread--given the sophisticated, helpful contribNeuroInvestment-11/1/2006
1Here is a link to the previous discussion on Paion siliconinvestor.comdr.praveen-11/1/2006
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News